emla
Emla is a combination medicine containing Lidocaine and Prilocaine.
Lidocaine and Prilocaine · by Teva Branded Pharm
Key facts
- Active ingredient
- Lidocaine and Prilocaine
- Form
- Topical, Disc
- Strength
- Lidocaine 2.5%; Prilocaine 2.5% **Federal Register Determination That Product was not Discontinued or Withdrawn for Safety or Effectiveness reasons**
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Teva Branded Pharm
- What the pharmacy pays
- ~$0.29 per ml — not your price
- FDA application
- NDA019941
- Availability
- Discontinued (per FDA)
Dosage forms
Topical and Disc
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- How much does Emla cost?
- Nobody can tell you what you will pay — your price is set by your insurer's formulary, your deductible and the pharmacy's markup, and none of those are published. What IS published is what the pharmacy paid to acquire it: about $0.29 per ml, per the CMS NADAC survey. Treat that as the floor, not the quote — ask the pharmacist for the cash price as well as your copay, because for cheap generics the cash price often wins.
- Is there a coupon or discount for Emla?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Emla. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Emla?
- Emla is marketed by Teva Branded Pharm. You can see Teva Branded Pharm's full profile, rating, and other products on pharmaranks.
- Is Emla a brand-name or generic drug?
- Emla is a brand-name product with the active ingredient Lidocaine and Prilocaine.
- Is Emla available over the counter?
- No. Emla is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Emla come in?
- Emla is currently marketed as topical and disc, per the FDA's National Drug Code Directory.
- Is Emla FDA-registered?
- Emla is on record with the U.S. FDA under application number NDA019941. You can verify this on its official FDA label.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about LIDOCAINE AND PRILOCAINE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 1,352 reports naming LIDOCAINE AND PRILOCAINE — the active ingredient in Emla, and the FDA flagged 58% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- fatigue156 reports
- nausea121 reports
- diarrhoea107 reports
- vomiting80 reports
- pyrexia70 reports
- dyspnoea66 reports
- headache65 reports
- pneumonia62 reports
Read these as a signal, not a rate. A report does not mean LIDOCAINE AND PRILOCAINE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 25, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Emla head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
emla
New